Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University / Michelle Monje, MD/PhD |
Innovation Grants |
2016 |
California |
Modeling osteosarcoma to identify novel therapeutic targets.
|
Stanford University / Julien Sage |
Young Investigator Grants |
2006 |
California |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias |
University of California at Santa Cruz / Camilla Forsberg, PhD |
Innovation Grants |
2013 |
California |
Targeting TGFb Pathway Dependencies in Group 3 Medulloblastoma |
University of California San Francisco / Zulekha Qadeer, PhD |
Young Investigator Grants |
2019 |
California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma |
Board of Trustees of the Leland Stanford Junior University / Michelle Monje |
Catalyst Grants |
2021 |
California |
Targeting and imaging immunometabolic vulnerabilities in diffuse midline glioma |
The Regents of the University of California San Francisco / Pavithra Viswanath, PhD |
Innovation Grants |
2024 |
California |
Pathological Condensates and Transcription Dysregulation in Rhabdomyosarcoma at Single-Molecule Resolution |
California Institute of Technology / Shasha Chong, PhD |
Innovation Grants |
2024 |
California |
Development of a comprehensive liquid biopsy-based genomics platform for pediatric solid tumors |
Children’s Hospital Los Angeles / Jaclyn Biegel |
Catalyst Grants |
2023 |
California |